Clinical Trials
Study Title:
A Phase II Study of Metronomic and Targeted Anti Angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma
|
For more information about the trial above please contact the study team:
Medical University of South Carolina
Principal Investigator, Jacqueline Kraveka, at kravekjm@musc.edu.
Study Coordinator, Jared Hortman, at hortman@musc.edu.
Trial opened at the following institutions: Medical University of South Carolina |